A Cross‐cultural Community Based Study of Dementias: Methods and Performance of the Survey Instrument, Indianapolis, U.S.A., and Ibadan, Nigeria

Hall, Kathleen; Ogunniyi, Adesola; Hendrie, Hugh C.; Osuntokun, B. O.; Hui, Siu L.; Musick, Beverly; Rodenberg, Cynthia; Unverzagt, Frederick W.; Guerje, Oyewusi; Baiyewu, Olusegun

doi:10.1002/(sici)1234-988x(199610)6:3<129::aid-mpr164>3.3.co;2-a

Cited by 91 publications

(104 citation statements)

References 0 publications

Supporting

Mentioning

100

Contrasting

Unclassified

Order By: Relevance

“…10 For individuals in the original baseline cohort, we tracked changes in scores over each successive screening interview and categorized the decline in scores as "poor performance" (7% with most decline), "intermediate performance" (8 to 14% decline group), and "good performance" (stable scores, improvement, or minimal decline). This resulted in 75% in the good performance group, approximately 13% in the intermediate group, and 12% in the poor performance group.…”

Section: Methodsmentioning

confidence: 99%

Cholesterol, APOE genotype, and Alzheimer disease

Hall¹,

Murrell²,

Ogunniyi³

et al. 2006

Neurology

121

View full text Add to dashboard Cite

Objective-To examine the relationship between cholesterol and other lipids, APOE genotype, and risk of Alzheimer disease (AD) in a population-based study of elderly Yoruba living in Ibadan, Nigeria.Methods-Blood samples and clinical data were collected from Yoruba study participants aged 70 years and older (N = 1,075) as part of the Indianapolis-Ibadan Dementia Project, a longitudinal epidemiologic study of AD. Cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglyceride levels were measured in fasting blood samples. DNA was extracted and APOE was genotyped. Diagnoses of AD were made by consensus using National Institute of Neurologic Disorders/Stroke-Alzheimer's Disease and Related Disorders Association criteria.Results-Logistic regression models showed interaction after adjusting for age and gender between APOE-ε4 genotype and biomarkers in the risk of AD cholesterol*genotype (p = 0.022), LDL*genotype (p = 0.018), and triglyceride*genotype (p = 0.036). Increasing levels of cholesterol and LDL were associated with increased risk of AD in individuals without the APOE-ε4 allele, but not in those with APOE-ε4. There was no significant association between levels of triglycerides and AD risk in those without APOE-ε4.Conclusions-There was a significant interaction between cholesterol, APOE-ε4, and the risk of Alzheimer disease (AD) in the Yoruba, a population that has lower cholesterol levels and lower incidence rates of AD compared to African Americans. APOE status needs to be considered when assessing the relationship between lipid levels and AD risk in population studies.The APOE-ε4 allele is a risk factor for Alzheimer disease (AD) in most populations. 1 The association between APOE-ε4 and AD for African Americans is less clear with some studies reporting no association 2 and others a weak association, 3 perhaps confined to the homozygous state. 4 We found no association between possession of the APOE-ε4 allele and AD in Yoruba residing in Nigeria. 5 There is increasing evidence that cholesterol plays a role in AD pathology, perhaps through its effects on amyloid deposition. 6 We have previously reported a significant interaction between APOE-ε4, cholesterol, and AD in African Americans in whom increasing We report on the interaction between APOE-ε4, cholesterol, and other lipids on the risk of AD in a population-based cohort of Yoruba who were evaluated as part of the IndianapolisIbadan Dementia Project. MethodsSince 1992, we have been conducting a comparative, community-based epidemiologic study of prevalence rates, incidence rates, and risk factors for AD in populations of African origin, elderly African Americans in Indianapolis, IN, and Yoruba living in Ibadan, Nigeria. Study participants have been evaluated at approximately 36-month intervals; this report focuses on the Ibadan site, which is located in the southwestern part of Nigeria where the predominant ethnic group is the Yoruba.In 2001, we conducted a two-stage study in which survivors of the 1992 cohort were ...

show abstract

Section: Methodsmentioning

confidence: 99%

Cholesterol, APOE genotype, and Alzheimer disease

Hall¹,

Murrell²,

Ogunniyi³

et al. 2006

Neurology

121

View full text Add to dashboard Cite

show abstract

“…Sub-samples of the study participants were selected for clinical assessment according to established cut-off scores that were derived from discriminant function analysis. Details of these had been described (Hall et al, 1996). The clinical assessment included a structured interview with an informant, neuropsychological testing, and examination by a physician as well as laboratory and imaging studies.…”

Section: Methodsmentioning

confidence: 99%

Risk factors for incident Alzheimer's disease in African Americans and Yoruba

et al. 2006

View full text Add to dashboard Cite

“…12,15,16,[18][19][20][21][22][23] In one paper, two studies were reported, and we considered these studies separately. 24 Because of considerable heterogeneity in methods (sampling and study design), population samples (age, health, socioeconomic status, geographical region and cultural background) and screening or diagnostic measures, we did not pool the data but report our findings in narrative form.…”

Section: Data Extraction and Analysismentioning

confidence: 99%

“…Only three studies documented evidence that confirmed the reliability of the tools. 12,15,16,[18][19][20][21][22][23]30,32 Three studies did not report confidence intervals (or information necessary to calculate them) 27,29,32 and one did not report a confidence interval but provided enough information for this to be calculated. 33 One study did not document sufficient information regarding appropriate probability sampling.…”

Section: Study Characteristicsmentioning

confidence: 99%

“…Differences between the studies included use of a single validated screening tool, the adapted 10-Word Delay Recall Test (10-WDRT), to define probable dementia in the 2006 study 30 and a combination of screening tools (including the 10-WDRT) and clinical assessment, to define dementia in the 1995 study. 12,15,16,[18][19][20][21][22][23] The 2006 study also covered a wider region, including rural areas, while the earlier study was conducted in an inner-city region.…”

Section: Nigeriamentioning

confidence: 99%

See 1 more Smart Citation